Affiliation:
1. Department of Medicine, University of Michigan Medical Center, Ann Arbor.
Abstract
Cardiovascular conditions account for more medical costs than any other diagnostic category in the United States. Increasingly, economic constraints will shape policy related to health care and research. Hypertension is the most common cardiovascular condition, and despite low unit health care costs, the aggregate costs are considerable. However, the unit and aggregate costs of the complications of hypertension are fourfold greater and, in this economic perspective, aggressive approaches are warranted to prevent complications. Treatment and research strategies should be identified that could have considerable potential economic impact. Several strategies are suggested as a prospective guide to policy development. Economic considerations will be important and should be incorporated in the planning of hypertension care and research.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference9 articles.
1. Parson PE Lichtenstein R Berki SE Murt HA Lepkowski JM Stehouwer SA Landis JR: The Costs of Illnesses United States 1980. National Medical Care Utilization and Expenditure Survey. National Center for Health Statistics Public Health Service Series C No. 3 Dept of Health and Human Services publication No. 86-20403. Washington DC US Government Printing Office 1986
2. A Hard Look at Cost Containment
3. Cost-effective Cardiology: The New Challenge
4. Harlan WR Thomas JW Hurt HA Lepkowski JM Guire KE Parsons PE Berki SE Landis JR: Health Care Utilization and Costs of Adult Cardiovascular Disease. National Medical Care Utilization and Expenditure Survey. National Center for Health Statistics Public Health Service Series C No. 7 Dept of Health and Human Services publication No. 89-20407. Washington DC US Government Printing Office 1989
5. Opportunities for improving the cost-effectiveness of antihypertensive treatment
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献